Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge
Journal of Allergy and Clinical Immunology, 12/10/2009
Clinical Article
Eckman JA et al. – Reduction in nasal symptom scores occurred when the basophil, but not mast cell, response was reduced on omalizumab, implicating a role for basophils in the acute NAC response.






